Vimarsana
Biggest News Aggregation in the World

Page 5 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aadi Bioscience Today - Breaking & Trending Today

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 7,037 Shares - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Neil Desai Sells 7,037 Shares

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the sale, the chairman now owns 1,537,543 shares of the company’s stock, […]

Neil Desai Sells 7,037 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stock - Vimarsana News

Neil Desai Sells 7,037 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 7,037 shares of the stock in a transaction on Wednesday, December 6th. The shares were sold at an average price of $4.82, for a total value of $33,918.34. Following the completion of the sale, the chairman now owns 1,537,543 shares in the company, […]

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $42,903.58 in Stock - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $42,903.58 in Stock

Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 8,347 shares of the business’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $5.14, for a total transaction of $42,903.58. Following the completion of the sale, the chairman now owns 1,571,196 shares in the […]

Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period (2019-2032) - Vimarsana News

Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period (2019-2032)

Apart from the already existing players such as Pfizer, Sanofi, Taiho Pharma, Ono Pharma, along with others, there are several emerging key players, that are...

Aadi Bioscience, Inc. (NASDAQ:AADI) Q3 2023 Earnings Call Transcript - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Q3 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.